logo image
search icon
Global Radiation Therapy Quality Assurance Phantoms Market

Radiation Therapy Quality Assurance Phantoms Market Size, Share & Trends Analysis Report By Technology (Linear Accelerators, Cobalt-60, High-Dose Radiation, Low-Dose Radiation), By Therapy, By Region, And By Segment Forecasts, 2024-2031

Report ID : 1384 | Published : 2024-05-29 | Pages: 185 | Format: PDF/EXCEL

The Radiation Therapy Quality Assurance Phantoms Market Size is valued at 28.94 Million in 2023 and is predicted to reach 47.34 Million by the year 2031 at a 6.52 % CAGR during the forecast period for 2024-2031. 

Key Industry Insights & Findings from the Report:

  • Rising demand for phantoms for tumor and cancer treatment is driving the radiation therapy quality assurance phantoms market.
  • Technological advancements in radiation therapy equipment and quality assurance techniques are driving the radiation therapy quality assurance phantoms market.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • Radiation therapy quality assurance phantoms face regulatory hurdles and safety concerns are a challenge for the market.

radiation therapy QA

One medical discipline that uses radiation to treat cancer is radiation oncology. As part of quality control methods, the machines are tested daily, monthly, and annually using phantoms. In the realm of medical imaging, phantoms are specially created objects that are utilized for the testing, grading, and calibration of various imaging equipment. Dose calibration, beam calibration, patient location, and treatment planning system are a few of the main areas examined during quality assurance using phantoms. The rising prevalence of diseases like cancer is anticipated to fuel the growth of the radiation therapy quality assurance phantoms market. Innovative imaging phantoms are in high demand due to the rise in diagnostic imaging facilities and the requirement for in-house calibration methods.

The growing need for improved phantoms is anticipated to be significantly influenced by the increased prevalence of diseases such as chronic ailments, cancers of all kinds, and heart failure. These phantoms can aid in examining the possibilities of imaging systems' early detection capabilities. Therefore, it is anticipated that using radiation therapy quality assurance phantoms to increase the effectiveness of equipment like X-rays, CT scan, and MRI will significantly contribute to market growth.

The market for radiation therapy quality assurance phantoms, on the other hand, is predicted to increase slowly over the timeline because of the rise in concerns over costs. The market for radiation treatment quality assurance phantoms is confronted with several problems, including greater end-user knowledge of safety and reliability procedures and strict government restrictions, which could somewhat restrain its global demand in the next few years.

and evaluate radiation therapy quality, rising cancer prevalence, and, most significantly, increasing demand for phantoms.

Competitive Landscape

Some Major Key Players In The Radiation Therapy Quality Assurance Phantoms Market:

  • Computerized Imaging Reference Systems, Inc.
  • Fluke Biomedical
  • IBA Dosimetry
  • Modus Medical Devices Inc.
  • PTW Freiburg GmbH
  • Standard Imaging Inc.
  • Sun Nuclear Corporation
  • The Phantom Laboratory, In.

Market Segmentation:

The radiation therapy quality assurance phantoms market is segmented on the basis of technology and therapy. Based on technology, the market is characterized by linear accelerators, cobalt-60, high-dose radiation, and low-dose radiation. Based on therapy, the market is characterized by external radiation therapy (Photon Beam Radiation Therapy, Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT), Volumetric Modulated Arc Therapy (VMAT), Image Guided Radiation Therapy (IGRT), Stereotactic Radiation Therapy, Intraoperative Radiotherapy (IORT), Proton Beam Therapy & Neutron Beam Therapy) and internal radiation therapy or brachytherapy.

Based On Technology, The Linear Accelerator Segment Is Accounted As A Major Contributor In The Radiation Therapy Quality Assurance Phantoms Market

The linear accelerator sector held the largest market share. The increased cancer incidence and product technological advancements are expected to drive the medical linear accelerator industry's expansion. Additionally, most cancers are found after they are well advanced. So, as the prevalence of cancer rises, will a need for therapy, which is expected to drive the growth of the medical linear accelerator market. High-energy x-rays are used in medical linear accelerators to kill cancerous cells and tumors while sparing nearby healthy tissues. The growing use of machine learning (ML) and artificial intelligence (AI) is transforming the market, primarily by increasing the effectiveness of cancer therapy with devices like linear accelerators.

The Internal Radiation Therapy Or Brachytherapy Segment Witnessed Growth At A Rapid Rate.

Brachytherapy is the type of radiation therapy that is most frequently used to treat cancer. Radiation therapy for the treatment of cancer includes brachytherapy. Catheters are used to insert radioactive materials into the body. Breast, head and neck, cervix, prostate, and ocular malignancies can all be treated with it. Following the planning of the treatment processes, brachytherapy quality assurance phantoms are used to assess area and volume, depth of penetration, distance, axial and lateral resolution, and geometric consistency. Additionally, the growing popularity of less invasive procedures will likely present more chances for the brachytherapy industry to expand in the coming years.

In The Region, The North American Radiation Therapy Quality Assurance Phantoms Market Holds A Significant Revenue Share.

During the forecast period, North America dominated the market, with the US and Canada accounting for most of the industry's revenue. This is primarily due to the country's sophisticated healthcare infrastructure, government support for growing the number of medical imaging devices to boost this industry's efficiency, growth in imaging device sales, and patient-centric philosophy. The substantial presence of significant medical technology companies, the rise in the use of radiotherapy equipment, and the growing emphasis on developing cutting-edge technologies and methodical radiation therapy for better patient care in the region are all variables that contribute to the rapid growth. In addition, Asia Pacific is anticipated to experience a CAGR in revenue that is noticeably higher. Government funding and increased R&D efforts are leading to the creation and adoption of more effective solutions, fueling the global market's revenue expansion. Other significant driving forces include expanding public awareness of the advantages of utilizing cutting-edge technologies to improve patient care.

Recent Developments:

  • In May 2023, IBA, a world leader in particle accelerator tech and radiation therapy quality assurance, presents its latest innovations at the European Society for Therapeutic Radiology and Oncology. Renowned for precision and safety in RT QA, IBA reinforces its industry leadership with cutting-edge solutions.

Radiation Therapy Quality Assurance Phantoms Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 28,94 Million

Revenue Forecast In 2031

USD 47.34 Million

Growth Rate CAGR

CAGR of 6.52 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Technology, Therapy

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation and The Phantom Laboratory, In

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Snapshot

Chapter 4. Global Radiation Therapy Quality Assurance (QA) Phantoms Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis

5.1. by Technology & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:

5.2.1. Linear Accelerators

5.2.2. Cobalt-60

5.2.3. High-Dose Radiation

5.2.4. Low-Dose Radiation

Chapter 6. Market Segmentation 2: by Therapy Estimates & Trend Analysis

6.1. by Therapy & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapy:

6.2.1. External Radiation Therapy

6.2.1.1. Photon Beam Radiation Therapy

6.2.1.2. Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)

6.2.1.3. Volumetric Modulated Arc Therapy (VMAT)

6.2.1.4. Image Guided Radiation Therapy (IGRT)

6.2.1.5. Stereotactic Radiation Therapy

6.2.1.6. Intraoperative Radiotherapy (IORT)

6.2.1.7. Proton Beam Therapy

6.2.1.8. Neutron Beam Therapy

6.2.2. Internal Radiation Therapy or Brachytherapy

Chapter 7. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

7.1.2. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2024-2031

7.1.3. North America Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe

7.2.1. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2024-2031

7.2.2. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2024-2031

7.2.3. Europe Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2024-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2024-2031

7.3.2. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2024-2031

7.3.3. Asia Pacific Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2024-2031

7.4. Latin America

7.4.1. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2024-2031

7.4.2. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2024-2031

7.4.3. Latin America Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2024-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Technology, 2024-2031

7.5.2. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by Therapy, 2024-2031

7.5.3. Middle East & Africa Radiation Therapy Quality Assurance (QA) Phantoms Market revenue (US$ Million) by country, 2024-2031

 

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Computerized Imaging Reference Systems, Inc.

8.2.2. Fluke Biomedical

8.2.3. IBA Dosimetry

8.2.4. Modus Medical Devices Inc.

8.2.5. PTW Freiburg GmbH

8.2.6. Standard Imaging Inc.

8.2.7. Sun Nuclear Corporation

8.2.8. The Phantom Laboratory, Inc.

8.2.9. Other Prominent Players

Segmentation Of Radiation Therapy Quality Assurance Phantoms Market

By Technology

  • Linear Accelerators
  • Cobalt-60
  • High-Dose Radiation
  • Low-Dose Radiation

Radiation Therapy Quality Assurance Phantoms Market

By Therapy

  • External Radiation Therapy
    • Photon Beam Radiation Therapy
    • Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
    • Image Guided Radiation Therapy (IGRT)
    • Stereotactic Radiation Therapy
    • Intraoperative Radiotherapy (IORT)
    • Proton Beam Therapy
    • Neutron Beam Therapy
  • Internal Radiation Therapy or Brachytherapy

By Region-

  • North America-
  • US
  • Canada
  • Mexico
  • Europe-
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific-
  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific
  • Latin America-
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa-
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Radiation Therapy Quality Assurance Phantoms Market Size?

The Radiation Therapy Quality Assurance Phantoms Market is expected to grow at a 6.52 % CAGR during the forecast period for 2024-2031.

Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., S

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach